Physician profile
Ravi Ranjan
NPI 1467505206
$344,692.91
in general payments reported to CMS, 2019-2025
10 companies · $44K in 2025
The $44K reported for 2025 was more than what 94% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $7,886 · 2021: $168K · 2022: $47K · 2023: $39K · 2024: $17K · 2025: $44K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $81K · Travel and Lodging: $19K · Food and Beverage: $895.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $80,846.02 |
| Travel and Lodging | $18,617.81 |
| Food and Beverage | $894.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $198,931.59 | 2019-2025 | Carto 3, Qdot Micro Catheter |
| Abbott Laboratories | $129,731.39 | 2019-2025 | Tacticath Ablation Catheter, Sensor Enabled, Ensite, Ensite Precision |
| Medtronic Vascular, INC. | $15,159.99 | 2019-2020 | |
| Medtronic, INC. | $568.47 | 2021-2025 | Micra, Aurora Ev-Icd Mri Surescan |
| Boston Scientific Corporation | $165.80 | 2019-2022 | |
| Chiesi USA, INC. | $38.30 | 2021-2022 | |
| Altathera Pharmaceuticals LLC | $37.15 | 2019 | |
| Cortex, INC. | $31.50 | 2024 | |
| Acutus Medical, INC. | $28.72 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ravi Ranjan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.